South East Asia Nutraceutical Excipients Market Size, Share & Trends Analysis Report By Function (Film Coating, Flow Aids, Thickeners, Binders, Modified Release), By Country, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 3 Business days
South East Asia Nutraceutical Excipients Market Growth & Trends
The South East Asia nutraceutical excipients market size is anticipated t%li%reach USD 1.36 billion by 2030. It is anticipated t%li%expand at a CAGR of 7.0% from 2025 t%li%2030, according t%li%a new report by Grand View Research, Inc. Increasing health awareness, high spending power, and rising drug resistance are primary factors contributing t%li%market growth. Growing consumer interest in health and wellness, combined with rising demand for functional foods and personalized nutrition, are key factors driving the nutraceutical excipient market growth.
The growing preference for health supplements, attributed t%li%advantages like enhanced immune support, enhanced mental health, and increased energy levels, is projected t%li%drive the demand for Nutraceuticals during the forecast period. Nutraceutical excipients play a crucial role in the formulation, effectiveness and stability of the nutraceuticals. The emergence of new delivery systems such as modified release and targeted delivery are enhancing the effects of nutraceuticals. Recently, convenient forms of nutraceuticals such as gummies, liquid formulations, and powders are trending.
Vitafoods Asia 2024 showcased various innovations in health-focused products, which highlighted the rapid expansion of the nutraceutical market in Asia. Such initiatives lead t%li%enhanced product offerings and a competitive edge in the market. Manufacturers get access t%li%the latest market research and consumer trends, which enables them t%li%plan and make better decisions.
South East Asia Nutraceutical Excipients Market Report Highlights
South East Asia Nutraceutical Excipients Market Growth & Trends
The South East Asia nutraceutical excipients market size is anticipated t%li%reach USD 1.36 billion by 2030. It is anticipated t%li%expand at a CAGR of 7.0% from 2025 t%li%2030, according t%li%a new report by Grand View Research, Inc. Increasing health awareness, high spending power, and rising drug resistance are primary factors contributing t%li%market growth. Growing consumer interest in health and wellness, combined with rising demand for functional foods and personalized nutrition, are key factors driving the nutraceutical excipient market growth.
The growing preference for health supplements, attributed t%li%advantages like enhanced immune support, enhanced mental health, and increased energy levels, is projected t%li%drive the demand for Nutraceuticals during the forecast period. Nutraceutical excipients play a crucial role in the formulation, effectiveness and stability of the nutraceuticals. The emergence of new delivery systems such as modified release and targeted delivery are enhancing the effects of nutraceuticals. Recently, convenient forms of nutraceuticals such as gummies, liquid formulations, and powders are trending.
Vitafoods Asia 2024 showcased various innovations in health-focused products, which highlighted the rapid expansion of the nutraceutical market in Asia. Such initiatives lead t%li%enhanced product offerings and a competitive edge in the market. Manufacturers get access t%li%the latest market research and consumer trends, which enables them t%li%plan and make better decisions.
South East Asia Nutraceutical Excipients Market Report Highlights
- The film coating segment held the largest market share of 12.4% in 2024.
- Modified release is anticipated t%li%witness the fastest growth of 8.0% over the forecast period, owing t%li%the rising demand for tailored formulations.
- Awareness about preventative healthcare, availability of personalized nutrition, and effective formulations are contributing t%li%the growing demand of nutraceutical excipients
- Singapore dominated the Southeast Asia nutraceutical excipients market in 2024 owing t%li%factors such as increasing health awareness, high purchasing power parity, and increasing innovations
- Cambodia nutraceutical excipients market is expected t%li%grow at the fastest CAGR of 8.7% over the forecast period
- Key players operating in the nutraceutical excipients market include SPI Pharma; DuPont; Dow; Barentz; Cargill, Incorporated; BASF; JRS PHARMA; BEHN MEYER; and Sensient Technologies Corporation
- In July 2024, Barentz expanded its presence in India by acquiring Anshul Life Sciences Group. This acquisition broadened Barentz's distribution network within the regulated personal care, pharmaceutical, and food & nutraceutical sectors in the country.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Function
1.2.2. Country Scope
1.2.3. Estimates and Forecasts Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Function outlook
2.2.2. Country outlook
2.3. Competitive Insights
CHAPTER 3. SOUTH EAST ASIA NUTRACEUTICAL EXCIPIENTS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. South East Asia Nutraceutical Excipients Market Analysis Tools
3.3.1. Industry analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. SOUTH EAST ASIA NUTRACEUTICAL EXCIPIENTS: FUNCTION ESTIMATES & TREND ANALYSIS
4.1. Function Segment Dashboard
4.2. South East Asia Nutraceutical Excipients Market: Function Movement Analysis
4.3. Film Coating
4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4. Flow Aids
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Taste Masking and Sweeteners
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Pharmaceuticals
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Thickeners
4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Preservatives
4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Lubricants
4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.10. Flavors
4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.11. Disintegrants
4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.12. Binders
4.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.13. Colors
4.13.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.14. Antifoams
4.14.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.15. Carriers
4.15.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.16. Sugars and Polyols (SOLID)
4.16.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.17. Sugars and Polyols (LIQUID)
4.17.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.18. Modified Release
4.18.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. SOUTH EAST ASIA NUTRACEUTICAL EXCIPIENTS MARKET: COUNTRY ESTIMATES & TREND ANALYSIS
5.1. Country Market Dashboard
5.2. Country Market Share Analysis, 2024 & 2030
5.3. South East Asia Nutraceutical Excipients Market by Country: Key Takeaways
5.4. Brunei
5.4.1. Key country dynamics
5.4.2. Regulatory framework/reimbursement structure
5.4.3. Competitive scenario
5.4.4. Brunei market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Indonesia
5.5.1. Key country dynamics
5.5.2. Regulatory framework/reimbursement structure
5.5.3. Competitive scenario
5.5.4. Indonesia market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Malaysia
5.6.1. Key country dynamics
5.6.2. Regulatory framework/reimbursement structure
5.6.3. Competitive scenario
5.6.4. Malaysia market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Philippines
5.7.1. Key country dynamics
5.7.2. Regulatory framework/reimbursement structure
5.7.3. Competitive scenario
5.7.4. Philippines market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Singapore
5.8.1. Key country dynamics
5.8.2. Regulatory framework/reimbursement structure
5.8.3. Competitive scenario
5.8.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Thailand
5.9.1. Key country dynamics
5.9.2. Regulatory framework/reimbursement structure
5.9.3. Competitive scenario
5.9.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
5.10. Vietnam
5.10.1. Key country dynamics
5.10.2. Regulatory framework/reimbursement structure
5.10.3. Competitive scenario
5.10.4. Vietnam market estimates and forecasts 2018 to 2030 (USD Million)
5.11. Burma (Myanmar)
5.11.1. Key country dynamics
5.11.2. Regulatory framework/reimbursement structure
5.11.3. Competitive scenario
5.11.4. Burma (Myanmar) market estimates and forecasts 2018 to 2030 (USD Million)
5.12. Cambodia
5.12.1. Key country dynamics
5.12.2. Regulatory framework/reimbursement structure
5.12.3. Competitive scenario
5.12.4. Cambodia market estimates and forecasts 2018 to 2030 (USD Million)
5.13. Timor-Leste
5.13.1. Key country dynamics
5.13.2. Regulatory framework/reimbursement structure
5.13.3. Competitive scenario
5.13.4. Timor-Leste market estimates and forecasts 2018 to 2030 (USD Million)
5.14. Laos
5.14.1. Key country dynamics
5.14.2. Regulatory framework/reimbursement structure
5.14.3. Competitive scenario
5.14.4. Laos market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Vendor Landscape
6.3.1. Key company heat map analysis, 2024
6.4. Company Profiles
6.4.1. SPI Pharma
6.4.1.1. Company overview
6.4.1.2. Financial performance
6.4.1.3. Product benchmarking
6.4.1.4. Strategic initiatives
6.4.2. DuPont
6.4.2.1. Company overview
6.4.2.2. Financial performance
6.4.2.3. Product benchmarking
6.4.2.4. Strategic initiatives
6.4.3. Dow
6.4.3.1. Company overview
6.4.3.2. Financial performance
6.4.3.3. Product benchmarking
6.4.3.4. Strategic initiatives
6.4.4. Barentz
6.4.4.1. Company overview
6.4.4.2. Financial performance
6.4.4.3. Product benchmarking
6.4.4.4. Strategic initiatives
6.4.5. Cargill, Incorporated
6.4.5.1. Company overview
6.4.5.2. Financial performance
6.4.5.3. Product benchmarking
6.4.5.4. Strategic initiatives
6.4.6. BASF
6.4.6.1. Company overview
6.4.6.2. Financial performance
6.4.6.3. Product benchmarking
6.4.6.4. Strategic initiatives
6.4.7. JRS PHARMA
6.4.7.1. Company overview
6.4.7.2. Financial performance
6.4.7.3. Product benchmarking
6.4.7.4. Strategic initiatives
6.4.8. BEHN MEYER
6.4.8.1. Company overview
6.4.8.2. Financial performance
6.4.8.3. Product benchmarking
6.4.8.4. Strategic initiatives
6.4.9. Sensient Technologies Corporation
6.4.9.1. Company overview
6.4.9.2. Financial performance
6.4.9.3. Product benchmarking
6.4.9.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Function
1.2.2. Country Scope
1.2.3. Estimates and Forecasts Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Function outlook
2.2.2. Country outlook
2.3. Competitive Insights
CHAPTER 3. SOUTH EAST ASIA NUTRACEUTICAL EXCIPIENTS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. South East Asia Nutraceutical Excipients Market Analysis Tools
3.3.1. Industry analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. SOUTH EAST ASIA NUTRACEUTICAL EXCIPIENTS: FUNCTION ESTIMATES & TREND ANALYSIS
4.1. Function Segment Dashboard
4.2. South East Asia Nutraceutical Excipients Market: Function Movement Analysis
4.3. Film Coating
4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4. Flow Aids
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Taste Masking and Sweeteners
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Pharmaceuticals
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Thickeners
4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Preservatives
4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Lubricants
4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.10. Flavors
4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.11. Disintegrants
4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.12. Binders
4.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.13. Colors
4.13.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.14. Antifoams
4.14.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.15. Carriers
4.15.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.16. Sugars and Polyols (SOLID)
4.16.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.17. Sugars and Polyols (LIQUID)
4.17.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.18. Modified Release
4.18.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. SOUTH EAST ASIA NUTRACEUTICAL EXCIPIENTS MARKET: COUNTRY ESTIMATES & TREND ANALYSIS
5.1. Country Market Dashboard
5.2. Country Market Share Analysis, 2024 & 2030
5.3. South East Asia Nutraceutical Excipients Market by Country: Key Takeaways
5.4. Brunei
5.4.1. Key country dynamics
5.4.2. Regulatory framework/reimbursement structure
5.4.3. Competitive scenario
5.4.4. Brunei market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Indonesia
5.5.1. Key country dynamics
5.5.2. Regulatory framework/reimbursement structure
5.5.3. Competitive scenario
5.5.4. Indonesia market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Malaysia
5.6.1. Key country dynamics
5.6.2. Regulatory framework/reimbursement structure
5.6.3. Competitive scenario
5.6.4. Malaysia market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Philippines
5.7.1. Key country dynamics
5.7.2. Regulatory framework/reimbursement structure
5.7.3. Competitive scenario
5.7.4. Philippines market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Singapore
5.8.1. Key country dynamics
5.8.2. Regulatory framework/reimbursement structure
5.8.3. Competitive scenario
5.8.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Thailand
5.9.1. Key country dynamics
5.9.2. Regulatory framework/reimbursement structure
5.9.3. Competitive scenario
5.9.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
5.10. Vietnam
5.10.1. Key country dynamics
5.10.2. Regulatory framework/reimbursement structure
5.10.3. Competitive scenario
5.10.4. Vietnam market estimates and forecasts 2018 to 2030 (USD Million)
5.11. Burma (Myanmar)
5.11.1. Key country dynamics
5.11.2. Regulatory framework/reimbursement structure
5.11.3. Competitive scenario
5.11.4. Burma (Myanmar) market estimates and forecasts 2018 to 2030 (USD Million)
5.12. Cambodia
5.12.1. Key country dynamics
5.12.2. Regulatory framework/reimbursement structure
5.12.3. Competitive scenario
5.12.4. Cambodia market estimates and forecasts 2018 to 2030 (USD Million)
5.13. Timor-Leste
5.13.1. Key country dynamics
5.13.2. Regulatory framework/reimbursement structure
5.13.3. Competitive scenario
5.13.4. Timor-Leste market estimates and forecasts 2018 to 2030 (USD Million)
5.14. Laos
5.14.1. Key country dynamics
5.14.2. Regulatory framework/reimbursement structure
5.14.3. Competitive scenario
5.14.4. Laos market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Vendor Landscape
6.3.1. Key company heat map analysis, 2024
6.4. Company Profiles
6.4.1. SPI Pharma
6.4.1.1. Company overview
6.4.1.2. Financial performance
6.4.1.3. Product benchmarking
6.4.1.4. Strategic initiatives
6.4.2. DuPont
6.4.2.1. Company overview
6.4.2.2. Financial performance
6.4.2.3. Product benchmarking
6.4.2.4. Strategic initiatives
6.4.3. Dow
6.4.3.1. Company overview
6.4.3.2. Financial performance
6.4.3.3. Product benchmarking
6.4.3.4. Strategic initiatives
6.4.4. Barentz
6.4.4.1. Company overview
6.4.4.2. Financial performance
6.4.4.3. Product benchmarking
6.4.4.4. Strategic initiatives
6.4.5. Cargill, Incorporated
6.4.5.1. Company overview
6.4.5.2. Financial performance
6.4.5.3. Product benchmarking
6.4.5.4. Strategic initiatives
6.4.6. BASF
6.4.6.1. Company overview
6.4.6.2. Financial performance
6.4.6.3. Product benchmarking
6.4.6.4. Strategic initiatives
6.4.7. JRS PHARMA
6.4.7.1. Company overview
6.4.7.2. Financial performance
6.4.7.3. Product benchmarking
6.4.7.4. Strategic initiatives
6.4.8. BEHN MEYER
6.4.8.1. Company overview
6.4.8.2. Financial performance
6.4.8.3. Product benchmarking
6.4.8.4. Strategic initiatives
6.4.9. Sensient Technologies Corporation
6.4.9.1. Company overview
6.4.9.2. Financial performance
6.4.9.3. Product benchmarking
6.4.9.4. Strategic initiatives
